To confirm clinical relevance, gene expression of SLBP, MBD1, DPH1, and CSNK1D was assessed in PC3 and DU145 PCa cell lines, showing significantly higher levels than in the normal prostate cell line RWPE-1, indicating potential involvement in cancer progression (Fig. 8b). Here, CSNK1D is linked to posterior cortical atrophy.